FDA Hits Guardian Drug for Lack of Quality Controls, Secure Data Post author:Sam Post published:April 11, 2017 Post category:Drug Industry Daily The FDA cited Guardian Drug Company over quality and data storage issues. Source: Drug Industry Daily You Might Also Like Gottlieb to Delayers of Generics: ‘End the Shenanigans’ November 8, 2017 IMDRF Guidances Offer Best Practices for Cybersecurity and Personalized Devices April 14, 2023 Positive Phase 3 Data Could Net Verona Pharma a First-in-Class COPD Treatment August 10, 2022
